The steps to commercialisation readiness are complex, multi-faceted and often left too late in the launch strategy of a pharmaceutical product. This can be particula...

In pharma R&D, the adverse event case intake process, which takes up so much of Safety/pharmacovigilance professionals’ time and is far from efficient in its sup...

In recent years, researchers have benefited from rapid advancements in analytical instrumentation, particularly in respect to liquid chromatography (LC). As a result...

As medical devices become more critical to patient outcomes, regulators around the world are steadily increasing controls around the manufacturing, distribution and ...

As medical device suppliers respond to rising regulatory scrutiny, they can expedite their preparations by looking at the lessons learned in pharma around product da...

Understanding medical device and drug-device combination (DDC) product regulation is essential when integrating medical devices into pharmacovigilance (PV) portfolio...